Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s stock price fell 4.4% during trading on Wednesday . The stock traded as low as $2.25 and last traded at $2.28. 254,887 shares were traded during trading, a decline of 95% from the average session volume of 4,782,219 shares. The stock had previously closed at $2.38.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on AGL. Sanford C. Bernstein upgraded shares of Agilon Health from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Barclays increased their price objective on shares of Agilon Health from $2.00 to $3.00 and gave the stock an "underweight" rating in a research note on Thursday, May 8th. The Goldman Sachs Group raised their target price on shares of Agilon Health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday, May 8th. Wells Fargo & Company cut their target price on shares of Agilon Health from $6.00 to $5.00 and set an "overweight" rating for the company in a research note on Tuesday, May 13th. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Agilon Health in a research report on Friday, March 21st. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $4.79.
Check Out Our Latest Analysis on Agilon Health
Agilon Health Stock Up 0.3%
The stock's 50-day simple moving average is $2.60 and its two-hundred day simple moving average is $3.21. The company has a market capitalization of $991.82 million, a price-to-earnings ratio of -4.06 and a beta of 0.16.
Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. Agilon Health had a negative net margin of 4.04% and a negative return on equity of 45.47%. The firm's revenue for the quarter was down 4.5% on a year-over-year basis. During the same period in the prior year, the business posted ($0.02) earnings per share. On average, sell-side analysts forecast that Agilon Health, Inc. will post -0.59 EPS for the current year.
Institutional Investors Weigh In On Agilon Health
A number of hedge funds have recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Agilon Health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock valued at $59,114,000 after purchasing an additional 272,787 shares during the period. Capital International Investors grew its holdings in shares of Agilon Health by 72.0% in the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC grew its holdings in shares of Agilon Health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock valued at $13,704,000 after purchasing an additional 4,706,357 shares during the period. Geode Capital Management LLC grew its holdings in shares of Agilon Health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after purchasing an additional 35,207 shares during the period. Finally, Goldman Sachs Group Inc. grew its holdings in shares of Agilon Health by 6.6% in the first quarter. Goldman Sachs Group Inc. now owns 5,060,333 shares of the company's stock valued at $21,911,000 after purchasing an additional 311,158 shares during the period.
Agilon Health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.